Skip to main content
Fig. 5 | Journal of Hematology & Oncology

Fig. 5

From: PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma

Fig. 5

a Progression-free survival (PFS) for NKTCL patients with a serum soluble PD-L1 of <3.4 and ≥3.4 ng/ml. b Overall survival (OS) for NKTCL patients with a serum soluble PD-L1 of <3.4 and ≥3.4 ng/ml. c PFS for NKTCL patients with a histological PD-L1 expression of <38 and ≥38 %. c OS for NKTCL patients with a histological PD-L1 expression of <38 and ≥38 %

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us